Our Mission
Current treatments for cancers like glioblastoma (GBM) may extend life by several months but are not curative and often have debilitating side effects. Investigational product Immune12, a marine-sourced complex biological, is currently being evaluated for its potential to be an effective, safe and easily delivered treatment for GBM and other challenging cancers. Pacific Marine Biotech (PMB) is a United States based company with a mission to bring this innovative product and its associated treatment method to the global health industry. If successful, we will realize our vision of
Changing the Way Cancer is Treated.
Press & Social
PMB Announces Partnership With EndBrainCancer.org
Pacific Marine Biotech is pleased to be a Patient Engagement Partner with EndBrainCancer.org (EBCI).
...and what this means to:
Patients & Caregivers
Pacific Marine Biotech is pleased to be a Patient Engagement Partner with EndBrainCancer.org (EBCI).
Health Care Providers
PMB’s focus is on launching clinical trials for GBM using its product, Immune12, a complex biologic compound derived from marine organisms.
Investors
PMB’s focus is on launching clinical trials for GBM using its product, Immune12, a complex biologic compound derived from marine organisms.